Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Chen, Wei Prof. Dr. (1) Daumke, Oliver Prof. Dr. (2) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Klußmann, Enno PD Dr. (1) Landthaler, Markus Prof. Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lewin, Gary Prof. Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Uckert, Wolfgang Prof. Dr. (2) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (13) (-) Selbach, Matthias Prof. Dr. (8) Ankerproteine und Signaltransduktion (1) Bioinformatik der Genregulation (2) (-) Molekulare Immunologie und Gentherapie (13) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Molekulare Signalwege in der kortikalen Entwicklung (1) (-) Proteom Dynamik (8) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (2) Strukturbiologie Membran-assoziierter Prozesse (2) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2013 (15) 2014 (15) 2015 (13) (-) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (9) 2024 (2) 21 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Selbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik19972016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto 01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling 07. April 2016 / Nat Biotechnol Receptor combinations hone T-cell therapy T. Blankenstein 01. Juli 2016 / Genome Res The mRNA-bound proteome of the early fly embryo H.H. Wessels K. Imami A.G. Baltz M. Kolinski A. Beldovskaya M. Selbach S. Small U. Ohler M. Landthaler 01. August 2016 / Mol Cell Proteomics Systematic errors in peptide and protein identification and quantification by modified peptides B. Bogdanow H. Zauber M. Selbach 22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling
01. Juli 2016 / Genome Res The mRNA-bound proteome of the early fly embryo H.H. Wessels K. Imami A.G. Baltz M. Kolinski A. Beldovskaya M. Selbach S. Small U. Ohler M. Landthaler
01. August 2016 / Mol Cell Proteomics Systematic errors in peptide and protein identification and quantification by modified peptides B. Bogdanow H. Zauber M. Selbach
22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler